LifeStance Health Group (NASDAQ:LFST) Shares Gap Up – Should You Buy?

LifeStance Health Group, Inc. (NASDAQ:LFST)’s share price gapped up before the market opened on Monday . The stock had previously closed at $7.17, but opened at $7.59. LifeStance Health Group shares last traded at $7.61, with a volume of 217,663 shares traded.

Analyst Ratings Changes

LFST has been the subject of several recent analyst reports. Barclays raised their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a report on Monday. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $8.70.

LifeStance Health Group Trading Down 3.5 %

The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The business’s fifty day moving average is $7.20 and its 200 day moving average is $6.36. The stock has a market cap of $2.86 billion, a PE ratio of -28.77 and a beta of 1.28.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.05. The business had revenue of $312.70 million for the quarter, compared to analysts’ expectations of $302.25 million. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.17) EPS. As a group, analysts predict that LifeStance Health Group, Inc. will post -0.2 earnings per share for the current year.

Insider Transactions at LifeStance Health Group

In related news, Director Robert Bessler sold 75,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $7.54, for a total value of $565,500.00. Following the sale, the director now owns 1,424,447 shares of the company’s stock, valued at approximately $10,740,330.38. This represents a 5.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 6.60% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

Hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP lifted its position in shares of LifeStance Health Group by 15.2% in the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company’s stock valued at $33,813,000 after acquiring an additional 638,385 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after purchasing an additional 235,316 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of LifeStance Health Group by 26.8% during the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after purchasing an additional 729,794 shares during the last quarter. State Street Corp grew its holdings in shares of LifeStance Health Group by 4.7% during the third quarter. State Street Corp now owns 2,750,656 shares of the company’s stock worth $19,255,000 after buying an additional 122,844 shares in the last quarter. Finally, Jennison Associates LLC raised its position in shares of LifeStance Health Group by 9.5% in the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after buying an additional 184,896 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.